NTS and irritable bowel syndrome: The serum neurotensin levels were significantly different among groups (p = 0.0257), and D-IBS(+) patients showed significantly (p < 0.05) lower neurotensin levels compared to healthy controls at the post hoc test (Figure 4(c)).